ARDT Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
1.6B
+0.2%
1.6B
+1.3%
1.6B
-0.2%
1.6B
+1.8%
1.6B
Cost of Revenue
0
0
0
0
0
Gross Profit
1.6B
+0.2%
1.6B
+1.3%
1.6B
-0.2%
1.6B
+1.8%
1.6B
Operating Expenses
1.5B
-2.4%
1.6B
+3.4%
1.5B
+1.0%
1.5B
-3.8%
1.6B
R&D
0
0
0
0
0
SG&A
975.7M
-2.8%
1.0B
+2.6%
978.5M
+1.8%
961.1M
-2.1%
982.0M
Operating Income
95.3M
+70.9%
55.8M
-35.7%
86.8M
-17.1%
104.8M
+536.5%
16.5M
EBITDA
136.4M
+40.5%
97.1M
-25.2%
129.8M
-11.0%
145.8M
+162.1%
55.6M
Net Income
63.4M
+82.7%
34.7M
-40.7%
58.5M
-21.2%
74.3M
+6052.6%
1.2M
EPS (Basic)
$0.32
+166.7%
$0.12
-57.1%
$0.28
-12.5%
$0.32
+288.2%
$-0.17
EPS (Diluted)
$0.31
+158.3%
$0.12
-57.1%
$0.28
-12.5%
$0.32
+288.2%
$-0.17
Shares (Diluted)
141.7M
-0.9%
143.1M
+0.9%
141.8M
-0.4%
142.4M
+0.8%
141.2M
Ardent Health (ARDT) — Financials